Not all therapeutic antibody isotypes are equal: the case of IgM versus IgG in Pertuzumab and Trastuzumab† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc04722k

The IgM antibody isotype of Pertuzumab affords simultaneous binding to antigens, but similar binding in Trastuzumab is hindered by steric clashes.

• Publication year

  2020

• Venue

  Chemical Science

• Publication date

  2020-02-12

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c9sc04722kPMID 32206268PMCID 7069520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of the IgE variable heavy chain in FcεRIα and superantigen binding in allergy and immunotherapy.

  2019cited by this paper
• CHARMM-GUI Glycan Modeler for modeling and simulation of carbohydrates and glycoconjugates

  2019cited by this paper
• Perspective: The promises of a holistic view of proteins—impact on antibody engineering and drug discovery

  2019cited by this paper
• The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein

  2018cited by this paper
• The effects of Antibody Engineering CH and CL in Trastuzumab and Pertuzumab recombinant models: Impact on antibody production and antigen-binding

  2018cited by this paper
• Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding

  2018cited by this paper
• Allosteric Effects between the Antibody Constant and Variable Regions: A Study of IgA Fc Mutations on Antigen Binding

  2018cited by this paper
• Evaluation of ENSO simulations in CMIP5 models: A new perspective based on percolation phase transition in complex networks

  2018cited by this paper
• In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus

  2018cited by this paper
• Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major

  2018cited by this paper
• IgG cooperativity – Is there allostery? Implications for antibody functions and therapeutic antibody development

  2017cited by this paper
• The role of Antibody Vκ Framework 3 region towards Antigen binding: Effects on recombinant production and Protein L binding

  2017cited by this paper
• Antibody Isotypes for Tumor Immunotherapy

  2017cited by this paper
• Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness

  2017cited by this paper
• High-throughput characterization of the functional impact of IgG Fc glycan aberrancy in juvenile idiopathic arthritis

  2017cited by this paper
• Broadband angle- and permittivity-insensitive nondispersive optical activity based on planar chiral metamaterials

  2017cited by this paper
• Architecture of Human IgM in Complex with P. falciparum Erythrocyte Membrane Protein 1.

  2016cited by this paper
• Emerging Functions of Natural IgM and Its Fc Receptor FCMR in Immune Homeostasis

  2016cited by this paper
• DrawGlycan-SNFG: a robust tool to render glycans and glycopeptides with fragmentation information

  2016cited by this paper
• Ig Constant Region Effects on Variable Region Structure and Function

  2016cited by this paper
• GRP78-directed immunotherapy in relapsed or refractory multiple myeloma - results from a phase 1 trial with the monoclonal immunoglobulin M antibody PAT-SM6

  2015cited by this paper
• GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

  2015cited by this paper
• Effects of N-glycosylation on protein conformation and dynamics: Protein Data Bank analysis and molecular dynamics simulation study

  2015cited by this paper
• CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data

  2013cited by this paper
• The Natural Human IgM Antibody PAT-SM6 Induces Apoptosis in Primary Human Multiple Myeloma Cells by Targeting Heat Shock Protein GRP78

  2013cited by this paper
• High-resolution structures of the IgM Fc domains reveal principles of its hexamer formation

  2013cited by this paper
• Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

  2012cited by this paper
• Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia

  2012cited by this paper
• MDAnalysis: A toolkit for the analysis of molecular dynamics simulations

  2011cited by this paper
• The importance of natural IgM: scavenger, protector and regulator

  2010cited by this paper
• The human IgM pentamer is a mushroom-shaped molecule with a flexural bias

  2009cited by this paper
• Combining an Elastic Network With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular Recognition.

  2009cited by this paper
• The MARTINI Coarse-Grained Force Field: Extension to Proteins.

  2008cited by this paper
• Canonical sampling through velocity rescaling.

  2007cited by this paper
• The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein

  2007cited by this paper
• Statistical potential for assessment and prediction of protein structures

  2006cited by this paper
• A composite score for predicting errors in protein structure models

  2006cited by this paper
• Human Serum IgM Glycosylation

  2005cited by this paper
• Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.

  2004cited by this paper
• A Critical Role for Induced IgM in the Protection against West Nile Virus Infection

  2003cited by this paper
• Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

  2003cited by this paper
• Evidence of allosteric conformational changes in the antibody constant region upon antigen binding.

  2003cited by this paper
• The crystal structure of IgE Fc reveals an asymmetrically bent conformation

  2002cited by this paper
• CCP4 NEWSLETTER ON PROTEIN CRYSTALLOGRAPHY

  2002cited by this paper
• B-1 and B-2 Cell–Derived Immunoglobulin M Antibodies Are Nonredundant Components of the Protective Response to Influenza Virus Infection

  2000cited by this paper
• Enhanced Virus Clearance by Early Inducible Lymphocytic Choriomeningitis Virus-Neutralizing Antibodies in Immunoglobulin-Transgenic Mice

  1998cited by this paper
• LINCS: A linear constraint solver for molecular simulations

  1997cited by this paper
• VMD: visual molecular dynamics.

  1996cited by this paper
• Polymer IgM assembly and secretion in lymphoid and nonlymphoid cell lines: evidence that J chain is required for pentamer IgM synthesis.

  1995cited by this paper
• A smooth particle mesh Ewald method

  1995cited by this paper
• IgM hexamers?

  1994cited by this paper
• Comparative protein modelling by satisfaction of spatial restraints.

  1993cited by this paper
• Disulfide bond assignment in human J chain and its covalent pairing with immunoglobulin M.

  1992cited by this paper
• Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection

  1991cited by this paper
• Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation.

  1991cited by this paper
• IgM--molecular requirements for its assembly and function.

  1989cited by this paper
• On the structure of polymeric IgM

  1988cited by this paper
• Polymeric immunoglobulin M is secreted by transfectants of non‐lymphoid cells in the absence of immunoglobulin J chain.

  1987cited by this paper
• Secondary structure of the immunoglobulin J chain.

  1985cited by this paper
• Canonical dynamics: Equilibrium phase-space distributions.

  1985cited by this paper
• The classical complement pathway: activation and regulation of the first complement component.

  1985cited by this paper
• Molecular dynamics with coupling to an external bath

  1984cited by this paper
• A unified formulation of the constant temperature molecular dynamics methods

  1984cited by this paper
• Primary structure of the immunoglobulin J chain from the mouse.

  1982cited by this paper
• Polymorphic transitions in single crystals: A new molecular dynamics method

  1981cited by this paper
• Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence.

  1975cited by this paper
• Conformation of the Free and Antigen-bound IgM Antibody Molecules

  1969cited by this paper
• Stereochemistry of polypeptide chain configurations.

  1963cited by this paper

• Targeting the epidermal growth factor receptor using IgM antibodies: toward next generation cancer immunotherapy

  2026cites this paper
• Defining the Features of Complement-Active IgM.

  2025cites this paper
• Prenatal Administration of Immunoglobulin-M (IgM) Via Transamniotic Fetal Immunotherapy (TRAFIT).

  2025cites this paper
• Harnessing IgM for solid tumor therapy: biology, engineering advances, and translational challenges

  2025cites this paper
• The administration of passive and active immunotherapy against Syntenin-1 decreased the tumoral growth and pulmonary metastasis in a murine model of triple-negative breast cancer

  2025cites this paper
• Understanding IgM Structure and Biology to Engineer New Antibody Therapeutics

  2025cites this paper
• Comprehensive review of drug resistance in mammalian cancer stem cells: implications for cancer therapy

  2024cites this paper
• A non-classical view of antibody properties: Allosteric effect between variable and constant regions.

  2024cites this paper
• A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma

  2023influential citation
• Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain

  2023cites this paper
• The synergistic effects of the VH families and CH regions of multimeric IgM on its interaction with FcμR, and antigen

  2022cites this paper
• Lateral Flow Assay for the Detection of African Swine Fever Virus Antibodies Using Gold Nanoparticle-Labeled Acid-Treated p72

  2022cites this paper
• Variable-heavy (VH) families influencing IgA1&2 engagement to the antigen, FcαRI and superantigen proteins G, A, and L

  2022cites this paper
• An IgM monoclonal antibody against domain 1 of CD147 induces non-canonical RIPK-independent necroptosis in a cell type specific hepatocellular carcinoma.

  2022cites this paper
• The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

  2022cites this paper
• IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2

  2022cites this paper
• Glyco engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues

  2022cites this paper
• The synergistic effects of the constant region and variable heavy chain families of multimeric immunoglobulin M on its interaction with Fc-mu receptor and antigen

  2022cites this paper
• A general Fc engineering platform for the next generation of antibody therapeutics

  2021cites this paper
• Allosteric perspective on the mutability and druggability of the SARS-CoV-2 Spike protein

  2021cites this paper
• Natural antibodies: Protecting role of IgM in glioblastoma and brain tumours.

  2021cites this paper
• How Communication Pathways Bridge Local and Global Conformations in an IgG4 Antibody: a Molecular Dynamics Study

  2021cites this paper
• More Than Meets the Kappa for Antibody Superantigen Protein L (PpL)

  2021cites this paper
• Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology

  2021cites this paper
• Engaging the ‘A’ Class Antibody: Variable-Heavy (VH) region influencing IgA1&2 engagement of FcαRI and superantigen proteins G, A, and L

  2021cites this paper
• Communication pathways bridge local and global conformations in an IgG4 antibody

  2021cites this paper
• Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective

  2021cites this paper
• Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles

  2020cites this paper
• Augmented reality in scientific visualization and communications: a new dawn of looking at antibody interactions

  2020cites this paper
• Perspective: The promises of a holistic view of proteins—impact on antibody engineering and drug discovery

  2019cites this paper